Cumberland Pharmaceuticals Inc. CPIX Income Statement

Cumberland pharmaceuticals inc. (CPIX)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net revenues
0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues:
Net revenues
-	-	-	-	-	-	-	-	-	-	-	36,177	34,924	-	31,981	31,074	32,569	33,519	34,810	36,654	37,495	36,901	35,732	32,531	29,862	32,027	37,564	43,567	48,853	48,851	48,186	48,709	50,732	51,142	50,301	47,987	0	0	0
Costs and expenses:
Cost of products sold
8,727	8,752	8,459	7,997	7,508	7,378	6,678	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of products sold
-	-	-	-	-	-	-	-	-	-	-	6,629	6,116	-	5,942	4,948	5,030	4,968	4,739	5,099	5,161	5,053	5,837	5,528	5,384	5,439	5,467	5,358	5,306	5,046	4,824	5,244	5,424	5,362	4,320	3,843	0	0	0
Selling and marketing
21,699	21,429	19,860	19,101	19,024	20,258	19,868	21,291	20,870	21,492	20,141	17,530	16,147	14,553	13,935	13,929	14,162	13,994	14,181	14,394	14,819	14,902	15,127	14,715	14,327	14,387	15,568	17,072	19,022	20,329	20,073	20,219	20,632	20,940	21,945	22,733	0	0	0
Research and development
6,801	6,478	7,080	7,108	7,100	7,575	5,989	5,626	5,256	4,280	4,082	3,784	3,382	3,190	2,433	2,545	2,695	3,847	4,211	4,388	4,422	3,389	3,961	4,467	4,993	5,615	4,717	4,973	5,139	5,095	6,412	5,948	5,422	5,028	4,408	4,210	0	0	0
General and administrative
9,861	10,362	10,906	10,551	10,357	10,150	9,829	9,852	9,871	9,651	9,298	9,072	8,594	8,561	7,833	7,762	8,041	7,607	7,798	8,161	8,148	8,401	9,295	9,096	8,811	9,489	9,142	9,074	9,366	9,055	9,087	9,346	9,570	9,307	8,329	7,963	0	0	0
Amortization
4,188	4,134	3,908	3,536	3,154	2,769	2,571	2,518	2,460	2,436	2,372	2,325	2,274	2,194	2,150	2,061	2,033	1,989	1,984	1,996	1,789	1,596	1,369	1,086	1,065	896	745	670	519	506	512	555	595	655	686	686	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Total costs and expenses
51,279	51,156	50,215	48,296	47,146	48,132	44,924	46,661	45,976	45,231	42,717	39,342	36,515	34,458	32,294	31,247	31,962	32,407	32,915	34,041	34,340	33,343	35,591	34,894	34,581	35,828	35,640	37,149	39,355	40,033	40,910	41,313	41,644	41,293	39,719	39,493	0	0	0
Operating income (loss)
-4,145	-3,623	-6,035	-5,995	-6,262	-7,390	-6,031	-5,063	-5,875	-4,081	-4,135	-3,165	-1,590	-1,433	-313	-172	606	1,111	1,895	2,613	3,154	3,558	140	-2,363	-4,719	-3,801	1,923	6,417	9,498	8,818	7,276	7,395	9,087	9,849	10,582	8,493	0	0	0
Interest income
157	243	361	578	597	564	480	409	329	299	261	218	180	204	191	203	229	209	224	268	240	251	273	185	205	230	210	297	324	304	319	263	240	210	196	194	0	0	0
Interest expense
218	246	353	307	238	195	81	71	79	92	99	119	117	106	97	88	78	73	69	76	70	67	92	89	97	103	78	71	67	71	80	96	159	353	876	1,249	0	0	0
Income (loss) from continuing operations before income taxes
-4,206	-3,625	-6,026	-5,724	-5,903	-7,022	-5,632	-4,725	-5,625	-3,874	-3,973	-3,067	-1,527	-1,334	-219	-57	758	1,246	2,050	2,805	3,324	3,743	322	-2,266	-4,611	-3,674	2,055	6,644	9,755	9,050	7,514	7,562	9,167	9,706	9,901	7,438	0	0	0
Income tax (expense) benefit
36	-79	-68	-68	-68	16	1,304	1,304	4,835	4,174	2,711	2,764	-812	-330	-114	21	382	575	859	1,006	1,211	1,380	119	-907	-1,894	-1,523	901	2,795	3,522	3,244	2,594	2,665	3,838	4,080	4,181	3,277	0	0	0
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss)
-4,571	-3,546	-4,811	-4,508	-4,687	-7,038	-5,623	-4,716	-9,148	-8,049	-7,997	-7,145	-2,028	-1,003	-105	-79	376	671	1,191	1,798	2,113	2,362	202	-1,359	-2,717	-2,151	1,153	3,848	6,233	5,806	4,920	4,897	5,329	5,626	5,719	4,160	0	0	0
Net (income) loss at subsidiary attributable to noncontrolling interests
-51	-8	-14	-21	-29	-75	-118	-111	-103	-71	-31	-28	-24	-59	-62	-57	-55	-60	-56	-68	-69	-61	-51	-47	-44	-46	-47	-42	-40	-36	-28	-29	-30	-31	-34	-33	0	0	0
Net income (loss) attributable to common shareholders
-4,519	-3,537	-4,797	-4,486	-4,657	-6,963	-5,543	-4,643	-9,083	-7,978	-7,927	-7,078	-1,966	-944	-42	-22	431	731	1,247	1,867	2,183	2,423	254	-1,311	-2,673	-2,104	1,201	3,890	6,273	5,842	4,948	4,926	5,359	5,657	5,754	4,194	0	0	0
Earnings (loss) per share attributable to common shareholders
Earnings (loss) per share attributable to common shareholders - Continuing operations - basic (in dollars per share)
-0.12	-	-	-	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings (loss) per share attributable to common shareholders - Discontinued operations - basic (in dollars per share)
0.05	-	-	-	0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings (loss) per share attributable to common shareholders - basic (in dollars per share)
-0.07	-0.06	-0.13	-0.04	0.00	-0.14	-0.11	-0.05	-0.15	-0.05	-0.05	-0.32	-0.08	-0.05	0.01	0.00	-0.02	0.01	0.01	0.02	0.00	0.04	0.04	0.04	0.02	-0.09	-0.04	-0.03	0.05	0.09	0.10	0.09	0.02	0.04	0.09	0.11	0.04	0.05	0.01
Earnings (loss) per share attributable to common shareholders - Continuing operations - diluted (in dollars per share)
-0.12	-	-	-	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings (loss) per share attributable to common shareholders - Discontinued operations - diluted (in dollars per share)
0.05	-	-	-	0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share)
-0.07	-0.06	-0.13	-0.04	0.00	-0.14	-0.11	-0.05	-0.15	-0.05	-0.05	-0.32	-0.08	-0.05	0.01	0.00	-0.02	0.01	0.01	0.02	0.00	0.04	0.04	0.04	0.02	-0.09	-0.04	-0.03	0.05	0.09	0.10	0.09	0.02	0.05	0.09	0.11	0.03	0.05	0.01
Weighted-average shares outstanding
- basic (in shares)
15,240	15,219	15,368	15,523	15,472	15,518	15,573	15,674	15,689	15,725	15,867	16,011	16,042	16,140	16,217	16,247	16,341	16,425	16,604	16,820	17,012	17,274	17,544	17,743	17,907	17,934	18,233	18,405	18,758	19,046	19,432	19,771	20,007	20,126	20,327	20,471	20,445	20,327	20,445
- diluted (in shares)
15,578	14,801	15,368	15,523	15,891	15,518	15,573	15,674	15,689	15,725	15,867	16,011	16,042	15,853	16,504	16,247	16,341	16,793	16,996	17,184	17,405	17,562	17,848	18,025	18,161	17,767	18,233	18,405	18,925	19,248	19,670	19,996	20,234	20,314	20,534	20,661	20,777	20,803	21,207
Comprehensive income (loss) attributable to common shareholders
-4,519	-3,537	-4,797	-4,486	-4,657	-6,963	-5,543	-4,643	-9,083	-7,978	-7,927	-7,078	-1,966	-944	-42	-22	431	731	1,247	1,867	2,183	2,423	934	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive (income) loss at subsidiary attributable to noncontrolling interests
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Total comprehensive income (loss)
-4,571	-3,546	-4,811	-4,508	-4,687	-7,038	-5,623	-4,716	-9,148	-8,049	-7,997	-7,145	-2,028	-1,003	-105	-79	376	671	1,191	1,798	2,113	2,362	202	-1,359	-2,717	-2,151	1,153	3,848	6,233	5,806	0	0	0	-	-	-	-	-	-